Prognostic value of five different histologic scoring systems for tumor regression after neoadjuvant chemotherapy of breast cancer in luminal type breast cancer

被引：0
|
作者：
Sinn, P.
Elsawaf, Z.
Kaip, G.
Hell, J.
Aulmann, S.
Marme, F.
Schneeweiss, A.
机构：
[1] Heidelberg Univ, Heidelberg, Germany
[2] Natl Ctr Tumor Dis, Heidelberg, Germany
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-P1-08-15
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-08-15
引用
收藏
页数：2
相关论文
共 50 条
  • [1] CONCENTRIC TUMOR SHRINKAGE BY CHEMOTHERAPY IS A GOOD PROGNOSTIC FACTOR IN NEOADJUVANT CHEMOTHERAPY FOR LUMINAL BREAST CANCER
    Fukada, I.
    Ito, Y.
    Takahashi, S.
    Tsutsumi, C.
    Kobayashi, T.
    Kobayashi, K.
    Nakayama, Y.
    Kawai, Y.
    Hatake, K.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 126 - 127
  • [2] Prognostic Value of Genomic Analysis after Neoadjuvant Chemotherapy for Breast Cancer
    Mayer, E. L.
    Shak, S.
    Miller, K.
    Rugo, H.
    Carey, L.
    Ryabin, N.
    Pomeroy, C.
    Yoshizawa, C.
    Winer, E. P.
    Burstein, H. J.
    [J]. CANCER RESEARCH, 2010, 70
  • [3] Prognostic value of subtype changes after neoadjuvant chemotherapy in primary breast cancer
    Matsumoto, Akiko
    Umemoto, Yasuko
    Yoshikawa, Mio
    Jinno, Hiromitsu
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [4] Prognostic Value of Receptor Change After Neoadjuvant Chemotherapy in Breast Cancer Patients
    Ozdemir, Ozlem
    Zengel, Baha
    Cavdar, Demet Kocatepe
    Yilmaz, Cengiz
    Durusoy, Raika
    [J]. EUROPEAN JOURNAL OF BREAST HEALTH, 2022, 18 (02) : 167 - 171
  • [5] The Prognostic Value of Lymph Node Involvement after Neoadjuvant Chemotherapy Is Different among Breast Cancer Subtypes
    Laot, Lucie
    Laas, Enora
    Girard, Noemie
    Dumas, Elise
    Daoud, Eric
    Grandal, Beatriz
    Pierga, Jean-Yves
    Coussy, Florence
    Kirova, Youlia
    El-Alam, Elsy
    Bataillon, Guillaume
    Lae, Marick
    Llouquet, Florence
    Reyal, Fabien
    Hamy, Anne-Sophie
    [J]. CANCERS, 2021, 13 (02) : 1 - 20
  • [6] The changes of the histologic and biologic markers after neoadjuvant chemotherapy in breast cancer
    Lee, K. M.
    Choi, U. J.
    [J]. BREAST, 2009, 18 : S62 - S62
  • [7] Prognostic factors after neoadjuvant chemotherapy in breast cancer: Surgery type as a new prognostic factor
    Fujihara, M.
    Kin, T.
    Yoshimura, Y.
    Kajiwara, Y.
    Ito, M.
    Ohtani, S.
    [J]. CANCER RESEARCH, 2017, 77
  • [8] Prognostic factors after neoadjuvant chemotherapy in breast cancer: Surgery type as a new prognostic factor
    Fujihara, M.
    Kin, T.
    Yoshimura, Y.
    Kajiwara, Y.
    Ito, M.
    Abe, K.
    Sakata, Y.
    Hiraki, K.
    Ohtani, S.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [9] Evaluation of Incomplete Tumor Regression Scores for Neoadjuvant Chemotherapy of Breast Cancer and Predictive Value of Immunohistology
    Sinn, H. P.
    Elsawaf, Z.
    Schirmacher, P.
    [J]. MODERN PATHOLOGY, 2009, 22 : 69A - 69A
  • [10] Evaluation of Incomplete Tumor Regression Scores for Neoadjuvant Chemotherapy of Breast Cancer and Predictive Value of Immunohistology
    Sinn, H. P.
    Elsawaf, Z.
    Schirmacher, P.
    [J]. LABORATORY INVESTIGATION, 2009, 89 : 69A - 69A
12345